Postmarket Safety Profile of Suicide/Self-injury for GLP-1 Receptor Agonist: A Real-World Pharmacovigilance Analysis

Eur Psychiatry. 2023 Nov 30:1-31. doi: 10.1192/j.eurpsy.2023.2474. Online ahead of print.NO ABSTRACTPMID:38031404 | DOI:10.1192/j.eurpsy.2023.2474
Source: Journal of the Association of European Psychiatrists - Category: Psychiatry Authors: Source Type: research